Reduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming
Journal of Arrhythmology · 13.06.2026 · 33 (2) · 58-64
DOI: 10.35336/va-1614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Arrhythmology, online erschienen am 13.06.2026. Verfasst von V. A. Amanatova und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Aim
Evaluation of a patient group with a reduced percentage of stimulation, pain sensation, and the impact of adjusting stimulation programming parameters on achieving a positive effect from cardiac contractility modulation (CCM) therapy.
Methods
The study included 117 patients implanted with a CCM device. Personalized parameter settings were programmed intraoperatively and postoperatively. Transthoracic echocardiography (TTE) was performed before implantation and 6 months after surgery.
Results
The median age was 59.5 years, with 93.7% being male patients. The primary etiology of heart failure was ischemic heart disease (53.8%). A part of patients required a reduction in stimulation amplitude from 7.5 V (79%) to a maximum of 5 V (9%). After 6 months, the group with 7.5 V stimulation amplitude showed a significant increase in LVEF to 37 [32; 43] % (p=0.0001). However, in the group with 5 V stimulation amplitude, the increase in LVEF did not reach statistical significance during follow-up: 35 [34; 40] (p=0.211). Patients without discomfort during CCM therapy had lower LVEF (p=0.048), increased LV volumes (p=0.024; p=0.034), and a thinner LV posterior wall (p=0.028). However, the relationship between cardiac wall thickness and pain during ССМ therapy requires further research. Also, in patients without stimulation discomfort, the electrodes were more frequently implanted in the middle third of the interventricular septum (p=0.025). 83.7% of patients were programmed with standard stimulation duration - 7 hours per day (hrs/day). For 5.9%, the stimulation duration was 10 to 14 hours due to failure to achieve the required stimulation percentage. In this patient group, increasing the stimulation duration achieved a stimulation percentage exceeding 70%. In 15.3% of cases, patients with a CCM device had a therapy percentage above 90%. In 68.3% of cases, the daily therapy percentage was 80- 90%, and in 12% - 70 to 80%. A positive, moderate, significant correlation was noted between the stimulation percentage and the increase in LVEF (r=0.3; p=0.05).
Conclusion
CCM is an effective method of interventional treatment for patients with CHF. When programming CCM devices, it is necessary to achieve a stimulation percentage exceeding 70% per day, as the stimulation percentage directly correlates with an increase in myocardial contractility. Additionally, the stimulation amplitude should reach the target level of 7.5 V. If pain occurs, a reduction in stimulation amplitude to the minimum tolerable level is permissible. Further study of the nuances of device operation and training of specialists in programming intracardiac devices are necessary.
Zitieren
APA
Amanatova, V. A., Mamedov, F. S., Grishin, I. R., Ardus, D. F., Sapelnikov, O. V., & Uskach, T. M. (2026). Reduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming. Journal of Arrhythmology, 33(2), 58-64. https://doi.org/10.35336/va-1614
Vancouver
Amanatova VA, Mamedov FS, Grishin IR, Ardus DF, Sapelnikov OV, Uskach TM. Reduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming. Journal of Arrhythmology. 2026;33(2):58-64. doi:10.35336/va-1614
BibTeX
@article{Amanatova2026,
author = {Amanatova, V. A. and Mamedov, F. S. and Grishin, I. R. and Ardus, D. F. and Sapelnikov, O. V. and Uskach, T. M.},
title = {Reduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming},
journal = {Journal of Arrhythmology},
year = {2026},
volume = {33},
number = {2},
pages = {58--64},
doi = {10.35336/va-1614}
}
EUVIMED